HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of carcinomatous cardiac tamponade due to breast cancer treated with OK-432 and mitomycin C].

Abstract
The patient was a 40-year-old woman who was admitted to our hospital because of severe cough and dyspnea due to multiple lung metastases from breast cancer, who had undergone Auchincloss operation for right breast cancer about five years earlier. While systemic chemotherapy (CAF) was started after admission,she presented with cardiac tamponade. A cardiac echogram revealed marked retention of pericardial effusion. Pericardiocentesis was carried out, and the cytology of the effusion showed class V, resulting in the diagnosis of carcinomatous cardiac tamponade due to breast cancer. She was treated with intrapericardial chemotherapy using OK-432 and mitomycin C (MMC), and has not suffered from pericardial effusion after the intrapericardial chemotherapy. Intrapericardial chemotherapy using OK-432 and MMC may be very useful for malignant pericardial effusion.
AuthorsShigeki Wakiyama, Ken Shirabe, Takashi Nagaie
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 34 Issue 3 Pg. 439-41 (Mar 2007) ISSN: 0385-0684 [Print] Japan
PMID17353639 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Picibanil
  • Mitomycin
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Breast Neoplasms (drug therapy, pathology, surgery)
  • Carcinoma, Ductal, Breast (drug therapy, secondary)
  • Cardiac Tamponade (drug therapy, etiology)
  • Drug Administration Schedule
  • Female
  • Humans
  • Lung Neoplasms (drug therapy, secondary)
  • Mitomycin (administration & dosage)
  • Pericardial Effusion (drug therapy, etiology, therapy)
  • Pericardiocentesis
  • Picibanil (administration & dosage)
  • Quality of Life

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: